BioBridge Global

What BioBridge Global does

BioBridge Global is a San Antonio, Texas-based nonprofit parent organization founded in 1973 (incorporated under its current name in 2013) that oversees four wholly-owned operating subsidiaries: South Texas Blood & Tissue, QualTex Laboratories, BBG Advanced Therapies, and The Blood & Tissue Center Foundation. Across 501–1,000 employees, the organization supplies more than 100 hospitals in 49 South Texas counties with over 400,000 blood components annually, screens 7 million+ blood and plasma donations per year through QualTex, and runs one of the largest independent nonprofit testing laboratories in the United States. Revenue is approximately $200 million (per a board vice chair disclosure), generated across four streams: transaction-fee blood component supply, transaction-fee testing, transaction-fee starting material sales, and professional-services biomanufacturing/clinical trial support.

The organization's technical infrastructure is anchored in regulated cGMP biomanufacturing: BBG Advanced Therapies operates 9 cGMP cleanrooms (EU Grades A–D) in a 6,700-square-foot manufacturing space supporting production up to 250L bioreactors, plus a 2,600-sq-ft Process Development Lab with Electronic Batch Records for real-time traceability. Fixed assets include FACT-accredited apheresis capabilities (both stationary and the world's first mobile leukapheresis center), the ACCELERATOR a3600 laboratory automation system at QualTex, and a research donor registry of 35,000+ recallable donors. Accreditations — AABB, FACT, CLIA, AATB, ISO 9001, EU GMP, and PMDA-aligned design — qualify production for FDA, EMA, and Japanese regulators.

BioBridge Global earns revenue through five channels: (1) blood and blood component supply to hospital systems (primary, transaction-fee), (2) testing services to national and international blood centers and biotech customers (QualTex), (3) cGMP biomanufacturing services for ATMP developers (professional services), (4) starting material collection and sale — RUO and cGMP leukopaks, cord blood, perinatal tissue (transaction fee), and (5) end-to-end leukapheresis services for clinical trials including recruitment, clearance, collection, testing, cryopreservation, and shipping. Go-to-market is primarily direct B2B sales to hospital systems in South Texas and direct enterprise engagement with biotech/pharma developers globally for advanced therapy services, supplemented by a community donor recruitment pipeline spanning mobile blood drives and donor centers across 49 counties.

Name

BioBridge Global

Legal name

BioBridge Global

Website

https://biobridgeglobal.org

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

251–500 employees

Short description

BioBridge Global is a San Antonio-based nonprofit parent organization operating South Texas Blood & Tissue, QualTex Laboratories, and BBG Advanced Therapies to supply blood, cell, and tissue products and cGMP biomanufacturing services to hospitals and cell and gene therapy developers.

Ownership category

akta.pro rank

Product category

Blood, Cell, and Tissue Banking / Advanced Therapy Biomanufacturing

NAICS

Blood and Organ Banks (621991), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• Blood and tissue banking
• Biopharmaceutical testing services
• Cell and gene therapy manufacturing
• Apheresis and leukapheresis services
• Cord blood and tissue services

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Blood and Blood Components: Supply of blood, plasma, platelets and other blood components to hospitals and healthcare providers throughout Texas. Provides over 400,000 units of blood to healthcare partners.
2. Testing Services: QualTex Laboratories screens millions of blood and plasma donations annually; provides biological testing for national and international biotech customers. One of the largest independent nonprofit testing laboratories in the US for blood and plasma products.
3. Biomanufacturing Services: cGMP biomanufacturing services for advanced therapy developers; process development, custom assay development, cell isolation and selection; 2,600 sq ft Process Development Lab; 6,700 sq ft biomanufacturing space supporting production up to 250L bioreactors
4. Starting Materials: Collection and sale of starting materials (leukopaks, cord blood, perinatal tissue) for advanced therapy manufacturing; both RUO and cGMP-grade products; allogeneic and autologous collections
5. Leukapheresis Services: Cell collection services for clinical trials through drug development, approval and commercialization; recruitment, clearance, collections, testing, cryopreservation and shipping

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

BioBridge Global provides blood, cell, and tissue products and services through its four subsidiaries: South Texas Blood & Tissue supplies blood components to more than 100 hospitals; QualTex Laboratories provides high-volume donor and biological testing; BBG Advanced Therapies provides cGMP biomanufacturing and starting materials (leukopaks, cord blood, perinatal tissue) plus leukapheresis services for cell and gene therapy developers; and The Blood & Tissue Center Foundation raises philanthropic support.

Product overview

BioBridge Global is a nonprofit organization operating as a platform of integrated subsidiaries providing blood, cell, and tissue products and services. The portfolio includes South Texas Blood & Tissue (community blood center supplying blood components to 100+ hospitals), QualTex Laboratories (testing services screening millions of samples annually), BBG Advanced Therapies (cGMP biomanufacturing and starting materials for advanced therapies including the Mobile Leukapheresis Center), The Blood & Tissue Center Foundation (philanthropic arm), and supporting services including cord blood banking, perinatal tissue services, tissue recovery, and custom services. The company leverages a unified Quality Management System with operations in San Antonio, TX and Norcross, GA.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood Services (South Texas Blood & Tissue) Nonprofit community blood center providing blood, plasma, platelets, and other blood components to more than 100 hospitals across 49 South Texas counties, supplying over 400,000 units of blood annually for transfusion, trauma, surgical, and cancer care.
• Testing Services (QualTex Laboratories) State-of-the-art testing laboratory providing donor screening, microbiology testing, advanced therapies testing, and immunohematology reference laboratory services; one of the largest independent nonprofit testing laboratories in the U.S., screening millions of blood and plasma donations annually for national and international biotech customers using the ACCELERATOR a3600 Laboratory Automation System.
• BBG Advanced Therapies Integrated cGMP biomanufacturing and advanced therapy services including starting material collection and processing, testing, and manufacturing services that bring transformative cell and gene therapies to patients; backed by 9 cGMP cleanrooms and the Process Development Lab and Biomanufacturing production suites.
• Biomanufacturing Services Integrated cGMP biomanufacturing services supporting transition from research to regulated production, including EU-graded modular cleanrooms (Grades A-D), HEPA filtration, 250L bioreactors, controlled-rate cryogenic units, and validated IQ/OQ/PQ workflows with Electronic Batch Records for ATMPs.
• Starting Materials High-quality starting materials including RUO and cGMP-grade leukopaks, allogeneic and autologous collections, umbilical cord blood, and birth tissue-derived products for advanced therapy developers.
• Leukapheresis Services End-to-end leukapheresis services including recruitment of more than 35,000 recallable research donors, donor clearance, cGMP leukapheresis collections, testing, cryopreservation, and shipping, with 15+ years of AABB-accredited and CLIA-certified experience.
• Mobile Leukapheresis Center World's first mobile leukapheresis center that brings immune cell collection directly to communities in South Texas (Laredo, Rio Grande Valley, Eagle Pass, Del Rio, Victoria) for cell and gene therapies targeting blood cancers, solid tumors, and autoimmune conditions.
• Cord Blood Services AABB-accredited cord blood services offering cell enumeration, characterization, and cryopreservation storage from the Texas Cord Blood Bank.
• Perinatal Tissue Services Full-service AATB-accredited tissue bank focused on perinatal tissue recovery, testing, distribution, and storage, with collection partners throughout South Texas.
• Tissue Recovery Services AATB-accredited tissue recovery services for musculoskeletal, skin, cardiac, and vascular tissues, performed at the Center for Life in collaboration with University Health System and other donation partners.
• Process Development Lab 2,600-square-foot Process Development Lab offering in-house analytical testing, custom assay development, cell isolation and selection, and optimization through scale-up to an 80L bioreactor.
• cGMP Manufacturing 6,700-square-foot biomanufacturing space supporting production volumes including 250L bioreactors, designed for FDA, EMA, and PMDA compliance for ATMPs and HCT/Ps.
• Custom Services Custom services including access to biomaterials, clinical research support, and publications for advanced therapy applications.
• The Blood & Tissue Center Foundation Nonprofit foundation that raises awareness and charitable funds to support the lifesaving activities of BioBridge Global and its subsidiaries.

Quantifiable outcome

• Over 450,000 lives saved through foundation-supported programs
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

16 partnerships are on record, tiered core and minor.

• VERIGRAFTcoreStrategic or Co-development Partner · 24 June 2026BBG Advanced Therapies collaboration with Swedish biotechnology company VERIGRAFT to support U.S. development and manufacturing readiness for VERIGRAFT's personalized tissue-engineered vein therapy (P-TEV). BBG AT provides donor vein sourcing, manufacturing, testing operations, and clinical trial preparation support for chronic venous insufficiency treatment.
• CELLforCUREcoreStrategic or Co-development Partner · 7 October 2025Transatlantic manufacturing partnership for Advanced Therapy Medicinal Products (ATMPs). Combines BBG Advanced Therapies' 9 cGMP cleanrooms in Texas with CELLforCURE's EMA-authorized, FDA-compliant 3,000 m² facility in France. Creates integrated global CDMO network enabling U.S. companies to access European manufacturing capacity and vice versa.
• University Health SystemcoreStrategic or Co-development PartnerCollaboration at the Center for Life facility; surgical suites for tissue recovery; partnership in organ, tissue, and eye donation support
• Texas Organ Sharing AlliancecoreStrategic or Co-development PartnerCollaboration for organ, tissue, and eye donation in South Texas service area
• San Antonio Eye BankcoreStrategic or Co-development PartnerPartnership for eye tissue donation and recovery services
• Donate Life TexascoreStrategic or Co-development PartnerStatewide organ, tissue, and eye donation registry partnership
• Miracles in Sight - Lone Star DivisionminorStrategic or Co-development PartnerEye tissue donation partnership
• University Transplant CenterminorStrategic or Co-development PartnerTransplant services partnership
• BioMedSAminorStrategic or Co-development PartnerSponsor of member-driven hub promoting and supporting the life sciences industry in San Antonio
• The Health CellminorStrategic or Co-development PartnerCollaboration with biotechnology, medical, military and academic leadership to promote professional development and collaboration in local healthcare community
• RegenMed SAcoreStrategic or Co-development PartnerPart of local organization formed to promote stem cell research, tissue engineering, regenerative medicine and biotechnology; Geoffrey Kindt serves on steering committee
• National Institutes of Health (NIH) - All of Us Research ProgramcoreStrategic or Co-development PartnerPartnership to recruit and engage participants in one of the nation's largest and most diverse health information databases
• Be The Match RegistrycoreChannel Partner/ Reseller/ DistributorSouth Texas Blood & Tissue joined the National Marrow Donor Program registry program and began collecting umbilical cord blood
• United WayminorStrategic or Co-development PartnerPacesetter organization with United Way, regularly surpassing goal for employee contributions to local nonprofit organizations
• H-E-BminorStrategic or Co-development PartnerCorporate partnership for blood drives and community events
• San Antonio SpursminorStrategic or Co-development PartnerPartnership for blood drives and community engagement events

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Vitalant: Vitalant is one of the largest nonprofit blood collection organizations in the U.S., operating community blood centers across multiple states. Directly comparable to BioBridge Global's South Texas Blood & Tissue subsidiary in donor recruitment, blood component supply to hospitals, and operational scope.
• American Red Cross Biomedical Services: The American Red Cross operates the largest U.S. blood collection, processing, and distribution network, supplying approximately 40% of the nation's blood supply. Directly comparable to BioBridge Global's hospital blood supply operations at significantly larger geographic and volume scale.
• OneBlood: OneBlood is a large nonprofit blood center serving Florida, the Southeast, and adjacent states. Comparable as a regional community blood center with hospital supply, apheresis services, and reference laboratory capabilities similar to BioBridge Global's South Texas Blood & Tissue operations.
• Carter BloodCare: Carter BloodCare is a Texas-based nonprofit blood center serving hospitals across North, Central, and East Texas. Directly comparable as a regional blood collection and hospital supply organization operating in overlapping Texas geography with similar hospital customer models.
• Versiti: Versiti is a Midwest-based nonprofit blood center and transfusion medicine research organization operating blood collection, testing, and cellular therapy services. Directly comparable to BioBridge Global across blood supply, diagnostic testing, and cell therapy support.
• New York Blood Center: New York Blood Center is a large nonprofit blood collection and research organization operating extensive blood banking, cord blood banking, and cellular therapy services. Comparable to BioBridge Global in combining legacy blood banking with advanced therapy and starting material offerings.
• HemaCare (Charles River Laboratories): HemaCare, now part of Charles River Laboratories, supplies leukopaks, apheresis collections, and starting materials to cell therapy developers. Directly comparable to BBG Advanced Therapies' starting materials and leukapheresis services offerings for ATMP customers.

Broad incumbents

• Lonza Cell & Gene Technologies: Lonza is a global contract development and manufacturing organization with a leading cell and gene therapy services franchise offering commercial-scale manufacturing, process development, and starting materials. Comparable as a much larger CDMO competitor in BBG Advanced Therapies' target market.
• Catalent Cell & Gene Therapy: Catalent is a global CDMO with extensive cell and gene therapy manufacturing capabilities including viral vectors, cell therapy production, and fill-finish. Comparable as a well-capitalized incumbent CDMO competing for the same ATMP manufacturing contracts as BBG Advanced Therapies.

Others

• Cryoport Systems: Cryoport provides temperature-controlled logistics and biostorage solutions for cell and gene therapies, including cryogenic shipping of apheresis products. Adjacent to BioBridge Global's cryopreservation and shipping operations within BBG Advanced Therapies' leukapheresis services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/biobridgeglobal
• YouTubeyoutube.com/@SouthTexasBlood
• Facebookfacebook.com/SouthTexasBloodandTissue
• LinkedInlinkedin.com/company/biobridgeglobal
• Instagraminstagram.com/southtexasblood

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioBridge Global